Nicardipine reduces risk of death and disability when given after intracerebral hemorrhage

Use of nicardipine to reduce systolic blood pressure (SBP) immediately after intracerebral hemorrhage (ICH) may improve outcomes, researchers say.

Reducing blood pressure after ICH appears to improve outcomes, but the optimal approach to antihypertensive therapy has not been defined. Intravenous nicardipine has a short-half life and is rapidly titratable, which may make it well suited for use after ICH.